Trials / Sponsors / Helix BioPharma Corporation
Helix BioPharma Corporation
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer Pancreas Cancer | Phase 1 / Phase 2 | 2019-12-11 |
| Terminated | A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma Lung Adenocarcinoma | Phase 2 | 2019-02-19 |
| Terminated | A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC Non-Small Cell Lung Cancer | Phase 1 | 2015-04-20 |
| Completed | A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47 Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2012-05-01 |